nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—Acitretin—psoriasis	0.251	1	CrCtD
Tretinoin—Retinoids—Tazarotene—psoriasis	0.165	0.5	CiPCiCtD
Tretinoin—Retinoids—Acitretin—psoriasis	0.165	0.5	CiPCiCtD
Tretinoin—Vitamin A—Acitretin—psoriasis	0.0536	0.333	CrCrCtD
Tretinoin—Alitretinoin—Acitretin—psoriasis	0.0536	0.333	CrCrCtD
Tretinoin—Isotretinoin—Acitretin—psoriasis	0.0536	0.333	CrCrCtD
Tretinoin—RARG—Tazarotene—psoriasis	0.0198	0.105	CbGbCtD
Tretinoin—RARA—Tazarotene—psoriasis	0.0175	0.0924	CbGbCtD
Tretinoin—RXRB—Tazarotene—psoriasis	0.0175	0.0924	CbGbCtD
Tretinoin—RARB—Tazarotene—psoriasis	0.0175	0.0924	CbGbCtD
Tretinoin—RARG—Acitretin—psoriasis	0.0157	0.0826	CbGbCtD
Tretinoin—RXRG—Acitretin—psoriasis	0.0157	0.0826	CbGbCtD
Tretinoin—RXRA—Acitretin—psoriasis	0.0138	0.073	CbGbCtD
Tretinoin—RXRB—Acitretin—psoriasis	0.0138	0.073	CbGbCtD
Tretinoin—RARA—Acitretin—psoriasis	0.0138	0.073	CbGbCtD
Tretinoin—RARB—Acitretin—psoriasis	0.0138	0.073	CbGbCtD
Tretinoin—NR0B1—Dexamethasone—psoriasis	0.00506	0.0267	CbGbCtD
Tretinoin—CYP1A1—Clobetasol propionate—psoriasis	0.00294	0.0155	CbGbCtD
Tretinoin—CYP4A11—Dexamethasone—psoriasis	0.00243	0.0128	CbGbCtD
Tretinoin—CYP2A6—Methoxsalen—psoriasis	0.00181	0.00955	CbGbCtD
Tretinoin—CYP1A1—Methoxsalen—psoriasis	0.00155	0.00816	CbGbCtD
Tretinoin—CYP2C8—Tazarotene—psoriasis	0.00138	0.0073	CbGbCtD
Tretinoin—CYP3A5—Beclomethasone—psoriasis	0.00134	0.00706	CbGbCtD
Tretinoin—CYP1A1—Cholecalciferol—psoriasis	0.00102	0.0054	CbGbCtD
Tretinoin—CYP2A6—Prednisolone—psoriasis	0.000879	0.00464	CbGbCtD
Tretinoin—CYP2B6—Cholecalciferol—psoriasis	0.00078	0.00412	CbGbCtD
Tretinoin—CRABP2—skin epidermis—psoriasis	0.0007	0.2	CbGeAlD
Tretinoin—CYP2C8—Cholecalciferol—psoriasis	0.000591	0.00312	CbGbCtD
Tretinoin—CYP3A7—Hydrocortisone—psoriasis	0.00057	0.00301	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.00057	0.00301	CbGbCtD
Tretinoin—CYP3A7—Cyclosporine—psoriasis	0.000538	0.00284	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.000538	0.00284	CbGbCtD
Tretinoin—CYP3A5—Mycophenolate mofetil—psoriasis	0.000533	0.00281	CbGbCtD
Tretinoin—CYP2A6—Dexamethasone—psoriasis	0.000518	0.00274	CbGbCtD
Tretinoin—CYP2C8—Mycophenolate mofetil—psoriasis	0.000512	0.0027	CbGbCtD
Tretinoin—CYP3A4—Calcitriol—psoriasis	0.000465	0.00245	CbGbCtD
Tretinoin—CYP1A1—Dexamethasone—psoriasis	0.000443	0.00234	CbGbCtD
Tretinoin—CYP3A5—Hydrocortisone—psoriasis	0.000427	0.00226	CbGbCtD
Tretinoin—CYP2C9—Cholecalciferol—psoriasis	0.000412	0.00217	CbGbCtD
Tretinoin—CYP2C8—Hydrocortisone—psoriasis	0.000411	0.00217	CbGbCtD
Tretinoin—CYP3A5—Cyclosporine—psoriasis	0.000404	0.00213	CbGbCtD
Tretinoin—CYP2C8—Cyclosporine—psoriasis	0.000388	0.00205	CbGbCtD
Tretinoin—CYP3A4—Methoxsalen—psoriasis	0.000362	0.00191	CbGbCtD
Tretinoin—CYP3A7—Dexamethasone—psoriasis	0.000354	0.00187	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.000354	0.00187	CbGbCtD
Tretinoin—CYP2B6—Dexamethasone—psoriasis	0.000337	0.00178	CbGbCtD
Tretinoin—RARRES1—skin of body—psoriasis	0.000324	0.0927	CbGeAlD
Tretinoin—CYP2C9—Cyclosporine—psoriasis	0.000271	0.00143	CbGbCtD
Tretinoin—CYP3A5—Dexamethasone—psoriasis	0.000266	0.0014	CbGbCtD
Tretinoin—CYP2C8—Dexamethasone—psoriasis	0.000256	0.00135	CbGbCtD
Tretinoin—RARRES1—tendon—psoriasis	0.000247	0.0705	CbGeAlD
Tretinoin—CRABP1—skin of body—psoriasis	0.00024	0.0686	CbGeAlD
Tretinoin—CYP3A4—Cholecalciferol—psoriasis	0.00024	0.00126	CbGbCtD
Tretinoin—CRABP2—skin of body—psoriasis	0.000217	0.062	CbGeAlD
Tretinoin—CYP3A4—Mycophenolate mofetil—psoriasis	0.000208	0.0011	CbGbCtD
Tretinoin—CYP3A4—Triamcinolone—psoriasis	0.000208	0.0011	CbGbCtD
Tretinoin—CRABP1—tendon—psoriasis	0.000183	0.0522	CbGeAlD
Tretinoin—ALDH1A1—skin of body—psoriasis	0.000181	0.0517	CbGeAlD
Tretinoin—CYP2C9—Dexamethasone—psoriasis	0.000178	0.000941	CbGbCtD
Tretinoin—CYP3A4—Betamethasone—psoriasis	0.000178	0.000941	CbGbCtD
Tretinoin—CYP3A4—Prednisolone—psoriasis	0.000176	0.000928	CbGbCtD
Tretinoin—CYP1A1—skin epidermis—psoriasis	0.000176	0.0502	CbGeAlD
Tretinoin—CYP3A4—Hydrocortisone—psoriasis	0.000167	0.00088	CbGbCtD
Tretinoin—CYP3A4—Prednisone—psoriasis	0.000166	0.000876	CbGbCtD
Tretinoin—CRABP2—tendon—psoriasis	0.000165	0.0472	CbGeAlD
Tretinoin—RARG—skin of body—psoriasis	0.000158	0.0453	CbGeAlD
Tretinoin—CYP3A4—Cyclosporine—psoriasis	0.000157	0.000831	CbGbCtD
Tretinoin—RARB—tendon—psoriasis	0.000148	0.0422	CbGeAlD
Tretinoin—RXRG—tendon—psoriasis	0.000144	0.0413	CbGeAlD
Tretinoin—ALDH1A1—tendon—psoriasis	0.000138	0.0393	CbGeAlD
Tretinoin—RXRB—tendon—psoriasis	0.000136	0.0388	CbGeAlD
Tretinoin—RARG—tendon—psoriasis	0.00012	0.0344	CbGeAlD
Tretinoin—RARA—tendon—psoriasis	0.000113	0.0324	CbGeAlD
Tretinoin—CYP3A4—Dexamethasone—psoriasis	0.000104	0.000547	CbGbCtD
Tretinoin—CYP1A1—skin of body—psoriasis	5.44e-05	0.0156	CbGeAlD
Tretinoin—CYP2B6—skin of body—psoriasis	5.29e-05	0.0151	CbGeAlD
Tretinoin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—psoriasis	2.58e-05	0.00149	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—CYP2S1—psoriasis	2.58e-05	0.00149	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—CYP2S1—psoriasis	2.58e-05	0.00149	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—CYP2S1—psoriasis	2.58e-05	0.00149	CbGpPWpGaD
Tretinoin—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	2.58e-05	0.00149	CbGpPWpGaD
Tretinoin—RARA—Adipogenesis—LEP—psoriasis	2.56e-05	0.00148	CbGpPWpGaD
Tretinoin—RXRA—Organelle biogenesis and maintenance—CARM1—psoriasis	2.56e-05	0.00148	CbGpPWpGaD
Tretinoin—RXRA—Transcription factor regulation in adipogenesis—TNF—psoriasis	2.55e-05	0.00148	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	2.54e-05	0.00147	CbGpPWpGaD
Tretinoin—RXRA—NRF2 pathway—TGFA—psoriasis	2.54e-05	0.00147	CbGpPWpGaD
Tretinoin—CYP2B6—Biological oxidations—CYP2S1—psoriasis	2.47e-05	0.00143	CbGpPWpGaD
Tretinoin—RXRA—Nuclear Receptor transcription pathway—PPARG—psoriasis	2.45e-05	0.00142	CbGpPWpGaD
Tretinoin—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	2.44e-05	0.00141	CbGpPWpGaD
Tretinoin—CYP3A5—Biological oxidations—CYP2S1—psoriasis	2.42e-05	0.0014	CbGpPWpGaD
Tretinoin—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	2.38e-05	0.00138	CbGpPWpGaD
Tretinoin—RXRG—Adipogenesis—PPARG—psoriasis	2.37e-05	0.00137	CbGpPWpGaD
Tretinoin—CYP1A1—Biological oxidations—CYP2S1—psoriasis	2.28e-05	0.00132	CbGpPWpGaD
Tretinoin—RARG—Generic Transcription Pathway—CARM1—psoriasis	2.27e-05	0.00131	CbGpPWpGaD
Tretinoin—CYP1A1—Metapathway biotransformation—CYP2S1—psoriasis	2.25e-05	0.0013	CbGpPWpGaD
Tretinoin—CYP1A1—Estrogen Receptor Pathway—STAT3—psoriasis	2.25e-05	0.0013	CbGpPWpGaD
Tretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—psoriasis	2.23e-05	0.00129	CbGpPWpGaD
Tretinoin—RARA—Adipogenesis—PPARG—psoriasis	2.23e-05	0.00129	CbGpPWpGaD
Tretinoin—CYP1A1—Melatonin metabolism and effects—APOE—psoriasis	2.21e-05	0.00128	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.17e-05	0.00126	CbGpPWpGaD
Tretinoin—CYP2C18—FOXA1 transcription factor network—JUN—psoriasis	2.16e-05	0.00125	CbGpPWpGaD
Tretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	2.15e-05	0.00124	CbGpPWpGaD
Tretinoin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	2.12e-05	0.00122	CbGpPWpGaD
Tretinoin—CYP2C8—Biological oxidations—CYP2S1—psoriasis	2.09e-05	0.00121	CbGpPWpGaD
Tretinoin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	2.09e-05	0.00121	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.08e-05	0.0012	CbGpPWpGaD
Tretinoin—RXRG—Generic Transcription Pathway—CARM1—psoriasis	2.08e-05	0.0012	CbGpPWpGaD
Tretinoin—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	2.06e-05	0.00119	CbGpPWpGaD
Tretinoin—RXRA—Transcription factor regulation in adipogenesis—IL6—psoriasis	2.06e-05	0.00119	CbGpPWpGaD
Tretinoin—RARB—Generic Transcription Pathway—CARM1—psoriasis	2.04e-05	0.00118	CbGpPWpGaD
Tretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—LEP—psoriasis	2.03e-05	0.00117	CbGpPWpGaD
Tretinoin—CYP1A1—Tryptophan metabolism—CAT—psoriasis	1.97e-05	0.00114	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—CARM1—psoriasis	1.95e-05	0.00113	CbGpPWpGaD
Tretinoin—RARA—Generic Transcription Pathway—CARM1—psoriasis	1.95e-05	0.00113	CbGpPWpGaD
Tretinoin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	1.84e-05	0.00106	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.83e-05	0.00106	CbGpPWpGaD
Tretinoin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	1.82e-05	0.00105	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—SOCS1—psoriasis	1.81e-05	0.00104	CbGpPWpGaD
Tretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARG—psoriasis	1.76e-05	0.00102	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.75e-05	0.00101	CbGpPWpGaD
Tretinoin—CYP2A6—NRF2 pathway—TGFA—psoriasis	1.71e-05	0.000986	CbGpPWpGaD
Tretinoin—CYP2C9—Biological oxidations—CYP2S1—psoriasis	1.7e-05	0.000985	CbGpPWpGaD
Tretinoin—RXRA—Regulation of Androgen receptor activity—JUN—psoriasis	1.69e-05	0.000975	CbGpPWpGaD
Tretinoin—NR0B1—Generic Transcription Pathway—VDR—psoriasis	1.68e-05	0.000973	CbGpPWpGaD
Tretinoin—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	1.68e-05	0.000971	CbGpPWpGaD
Tretinoin—CYP4A11—PPARA activates gene expression—PPARG—psoriasis	1.67e-05	0.000967	CbGpPWpGaD
Tretinoin—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	1.64e-05	0.000946	CbGpPWpGaD
Tretinoin—CYP1A1—PPARA activates gene expression—CARM1—psoriasis	1.59e-05	0.000922	CbGpPWpGaD
Tretinoin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	1.56e-05	0.000902	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—TARS—psoriasis	1.56e-05	0.0009	CbGpPWpGaD
Tretinoin—RXRG—Adipogenesis—STAT3—psoriasis	1.45e-05	0.00084	CbGpPWpGaD
Tretinoin—RARA—Adipogenesis—STAT3—psoriasis	1.37e-05	0.00079	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—CARM1—psoriasis	1.36e-05	0.000784	CbGpPWpGaD
Tretinoin—RARG—Generic Transcription Pathway—VDR—psoriasis	1.36e-05	0.000784	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.35e-05	0.000781	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.35e-05	0.000781	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—LEP—psoriasis	1.33e-05	0.00077	CbGpPWpGaD
Tretinoin—RXRA—PPARA activates gene expression—PPARG—psoriasis	1.33e-05	0.000767	CbGpPWpGaD
Tretinoin—CYP1A1—Melatonin metabolism and effects—NFKB1—psoriasis	1.32e-05	0.000761	CbGpPWpGaD
Tretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	1.3e-05	0.00075	CbGpPWpGaD
Tretinoin—CYP1A1—Oxidative Stress—NFKB1—psoriasis	1.28e-05	0.000741	CbGpPWpGaD
Tretinoin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	1.27e-05	0.000732	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—CARM1—psoriasis	1.26e-05	0.000728	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—CARM1—psoriasis	1.26e-05	0.000728	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—CARM1—psoriasis	1.26e-05	0.000728	CbGpPWpGaD
Tretinoin—RXRG—Adipogenesis—TNF—psoriasis	1.26e-05	0.000727	CbGpPWpGaD
Tretinoin—RXRG—Generic Transcription Pathway—VDR—psoriasis	1.24e-05	0.000717	CbGpPWpGaD
Tretinoin—RARB—Generic Transcription Pathway—VDR—psoriasis	1.22e-05	0.000703	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.21e-05	0.0007	CbGpPWpGaD
Tretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—NFKB1—psoriasis	1.2e-05	0.000696	CbGpPWpGaD
Tretinoin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	1.2e-05	0.000693	CbGpPWpGaD
Tretinoin—RARA—Adipogenesis—TNF—psoriasis	1.18e-05	0.000684	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.18e-05	0.00068	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.18e-05	0.00068	CbGpPWpGaD
Tretinoin—NR0B1—Generic Transcription Pathway—PPARG—psoriasis	1.17e-05	0.000678	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—VDR—psoriasis	1.17e-05	0.000674	CbGpPWpGaD
Tretinoin—RARA—Generic Transcription Pathway—VDR—psoriasis	1.17e-05	0.000674	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.17e-05	0.000674	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.16e-05	0.000671	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—PPARG—psoriasis	1.16e-05	0.000671	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—NDUFA5—psoriasis	1.16e-05	0.000669	CbGpPWpGaD
Tretinoin—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	1.13e-05	0.000652	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—CYP2S1—psoriasis	1.12e-05	0.000649	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.12e-05	0.000646	CbGpPWpGaD
Tretinoin—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	1.11e-05	0.000641	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	1.09e-05	0.000632	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—CARM1—psoriasis	1.09e-05	0.000632	CbGpPWpGaD
Tretinoin—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	1.09e-05	0.000632	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	1.09e-05	0.000628	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.08e-05	0.000624	CbGpPWpGaD
Tretinoin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	1.08e-05	0.000621	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.06e-05	0.000612	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—CARM1—psoriasis	1.02e-05	0.000588	CbGpPWpGaD
Tretinoin—RXRG—Adipogenesis—IL6—psoriasis	1.02e-05	0.000587	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.01e-05	0.000586	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—NDUFA5—psoriasis	1.01e-05	0.000585	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—CARM1—psoriasis	1e-05	0.000578	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—CYP2S1—psoriasis	9.84e-06	0.000569	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—CARM1—psoriasis	9.81e-06	0.000567	CbGpPWpGaD
Tretinoin—CYP3A4—Tryptophan metabolism—CAT—psoriasis	9.7e-06	0.00056	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—CARM1—psoriasis	9.58e-06	0.000554	CbGpPWpGaD
Tretinoin—RARA—Adipogenesis—IL6—psoriasis	9.55e-06	0.000552	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	9.46e-06	0.000547	CbGpPWpGaD
Tretinoin—RARG—Generic Transcription Pathway—PPARG—psoriasis	9.46e-06	0.000547	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—CARM1—psoriasis	9.41e-06	0.000544	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—CARM1—psoriasis	9.41e-06	0.000544	CbGpPWpGaD
Tretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—psoriasis	9.37e-06	0.000542	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—NDUFA5—psoriasis	9.18e-06	0.000531	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	9.13e-06	0.000528	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	9.1e-06	0.000526	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	9.07e-06	0.000524	CbGpPWpGaD
Tretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	8.95e-06	0.000517	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	8.69e-06	0.000502	CbGpPWpGaD
Tretinoin—RXRG—Generic Transcription Pathway—PPARG—psoriasis	8.65e-06	0.0005	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—CYP2S1—psoriasis	8.6e-06	0.000497	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—CARM1—psoriasis	8.56e-06	0.000495	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—CP—psoriasis	8.53e-06	0.000493	CbGpPWpGaD
Tretinoin—RARB—Generic Transcription Pathway—PPARG—psoriasis	8.48e-06	0.00049	CbGpPWpGaD
Tretinoin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.36e-06	0.000483	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	8.26e-06	0.000478	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—CARM1—psoriasis	8.14e-06	0.00047	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—PPARG—psoriasis	8.13e-06	0.00047	CbGpPWpGaD
Tretinoin—RARA—Generic Transcription Pathway—PPARG—psoriasis	8.13e-06	0.00047	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—VDR—psoriasis	8.1e-06	0.000468	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	8e-06	0.000462	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CYP2S1—psoriasis	7.81e-06	0.000451	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—CAT—psoriasis	7.74e-06	0.000448	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—CAT—psoriasis	7.74e-06	0.000448	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—CAT—psoriasis	7.74e-06	0.000448	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	7.67e-06	0.000443	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—STAT3—psoriasis	7.12e-06	0.000412	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriasis	7.08e-06	0.000409	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	7.08e-06	0.000409	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—NDUFA5—psoriasis	6.73e-06	0.000389	CbGpPWpGaD
Tretinoin—CYP1A1—PPARA activates gene expression—PPARG—psoriasis	6.64e-06	0.000384	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—VDR—psoriasis	6.53e-06	0.000377	CbGpPWpGaD
Tretinoin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	6.5e-06	0.000375	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—NDUFA5—psoriasis	6.16e-06	0.000356	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—TNF—psoriasis	6.16e-06	0.000356	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—VDR—psoriasis	6.08e-06	0.000351	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	6.05e-06	0.00035	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—APOE—psoriasis	6.02e-06	0.000348	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—APOE—psoriasis	6.02e-06	0.000348	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—APOE—psoriasis	6.02e-06	0.000348	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—VDR—psoriasis	5.97e-06	0.000345	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—VDR—psoriasis	5.86e-06	0.000339	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	5.83e-06	0.000337	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CYP2S1—psoriasis	5.72e-06	0.00033	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—PPARG—psoriasis	5.65e-06	0.000326	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—VDR—psoriasis	5.62e-06	0.000325	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—VDR—psoriasis	5.62e-06	0.000325	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	5.29e-06	0.000306	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—PPARG—psoriasis	5.24e-06	0.000303	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PPARG—psoriasis	5.24e-06	0.000303	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PPARG—psoriasis	5.24e-06	0.000303	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CYP2S1—psoriasis	5.24e-06	0.000303	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.16e-06	0.000298	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—IL6—psoriasis	4.97e-06	0.000287	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—NDUFA5—psoriasis	4.97e-06	0.000287	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—CARM1—psoriasis	4.9e-06	0.000283	CbGpPWpGaD
Tretinoin—Anxiety—Betamethasone—psoriasis	4.88e-06	0.000101	CcSEcCtD
Tretinoin—CYP3A5—Metabolism—NDUFA5—psoriasis	4.86e-06	0.000281	CbGpPWpGaD
Tretinoin—Vomiting—Mycophenolic acid—psoriasis	4.86e-06	0.000101	CcSEcCtD
Tretinoin—Discomfort—Betamethasone—psoriasis	4.84e-06	0.0001	CcSEcCtD
Tretinoin—Discomfort—Dexamethasone—psoriasis	4.84e-06	0.0001	CcSEcCtD
Tretinoin—Dyspepsia—Hydrocortisone—psoriasis	4.83e-06	0.0001	CcSEcCtD
Tretinoin—Haemoglobin—Methotrexate—psoriasis	4.83e-06	0.0001	CcSEcCtD
Tretinoin—Rash—Mycophenolic acid—psoriasis	4.82e-06	0.0001	CcSEcCtD
Tretinoin—Dermatitis—Mycophenolic acid—psoriasis	4.81e-06	9.99e-05	CcSEcCtD
Tretinoin—Pain—Prednisolone—psoriasis	4.81e-06	9.98e-05	CcSEcCtD
Tretinoin—Haemorrhage—Methotrexate—psoriasis	4.81e-06	9.98e-05	CcSEcCtD
Tretinoin—Hepatitis—Methotrexate—psoriasis	4.81e-06	9.98e-05	CcSEcCtD
Tretinoin—CYP4A11—Metabolism—CARM1—psoriasis	4.81e-06	0.000278	CbGpPWpGaD
Tretinoin—Urticaria—Mycophenolate mofetil—psoriasis	4.79e-06	9.94e-05	CcSEcCtD
Tretinoin—Headache—Mycophenolic acid—psoriasis	4.79e-06	9.93e-05	CcSEcCtD
Tretinoin—Decreased appetite—Hydrocortisone—psoriasis	4.77e-06	9.91e-05	CcSEcCtD
Tretinoin—Pharyngitis—Methotrexate—psoriasis	4.77e-06	9.9e-05	CcSEcCtD
Tretinoin—Body temperature increased—Mycophenolate mofetil—psoriasis	4.77e-06	9.89e-05	CcSEcCtD
Tretinoin—Abdominal pain—Mycophenolate mofetil—psoriasis	4.77e-06	9.89e-05	CcSEcCtD
Tretinoin—Urinary tract disorder—Methotrexate—psoriasis	4.75e-06	9.85e-05	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Hydrocortisone—psoriasis	4.74e-06	9.84e-05	CcSEcCtD
Tretinoin—Fatigue—Hydrocortisone—psoriasis	4.74e-06	9.83e-05	CcSEcCtD
Tretinoin—Vision blurred—Prednisone—psoriasis	4.72e-06	9.8e-05	CcSEcCtD
Tretinoin—Urethral disorder—Methotrexate—psoriasis	4.71e-06	9.78e-05	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Triamcinolone—psoriasis	4.71e-06	9.78e-05	CcSEcCtD
Tretinoin—Pain—Hydrocortisone—psoriasis	4.7e-06	9.75e-05	CcSEcCtD
Tretinoin—Anaphylactic shock—Betamethasone—psoriasis	4.69e-06	9.74e-05	CcSEcCtD
Tretinoin—Oedema—Dexamethasone—psoriasis	4.69e-06	9.74e-05	CcSEcCtD
Tretinoin—Oedema—Betamethasone—psoriasis	4.69e-06	9.74e-05	CcSEcCtD
Tretinoin—Anaphylactic shock—Dexamethasone—psoriasis	4.69e-06	9.74e-05	CcSEcCtD
Tretinoin—Insomnia—Triamcinolone—psoriasis	4.68e-06	9.71e-05	CcSEcCtD
Tretinoin—Infection—Betamethasone—psoriasis	4.66e-06	9.68e-05	CcSEcCtD
Tretinoin—Infection—Dexamethasone—psoriasis	4.66e-06	9.68e-05	CcSEcCtD
Tretinoin—Ill-defined disorder—Prednisone—psoriasis	4.65e-06	9.64e-05	CcSEcCtD
Tretinoin—Paraesthesia—Triamcinolone—psoriasis	4.64e-06	9.64e-05	CcSEcCtD
Tretinoin—Feeling abnormal—Prednisolone—psoriasis	4.63e-06	9.62e-05	CcSEcCtD
Tretinoin—Visual impairment—Methotrexate—psoriasis	4.63e-06	9.62e-05	CcSEcCtD
Tretinoin—Anaemia—Prednisone—psoriasis	4.63e-06	9.61e-05	CcSEcCtD
Tretinoin—Shock—Dexamethasone—psoriasis	4.62e-06	9.58e-05	CcSEcCtD
Tretinoin—Shock—Betamethasone—psoriasis	4.62e-06	9.58e-05	CcSEcCtD
Tretinoin—Dyspnoea—Triamcinolone—psoriasis	4.61e-06	9.57e-05	CcSEcCtD
Tretinoin—Nervous system disorder—Betamethasone—psoriasis	4.6e-06	9.55e-05	CcSEcCtD
Tretinoin—Nervous system disorder—Dexamethasone—psoriasis	4.6e-06	9.55e-05	CcSEcCtD
Tretinoin—Agitation—Prednisone—psoriasis	4.6e-06	9.55e-05	CcSEcCtD
Tretinoin—Thrombocytopenia—Betamethasone—psoriasis	4.59e-06	9.54e-05	CcSEcCtD
Tretinoin—Thrombocytopenia—Dexamethasone—psoriasis	4.59e-06	9.54e-05	CcSEcCtD
Tretinoin—CYP1A1—Metabolism—NDUFA5—psoriasis	4.59e-06	0.000265	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—LEP—psoriasis	4.58e-06	0.000265	CbGpPWpGaD
Tretinoin—Tachycardia—Betamethasone—psoriasis	4.58e-06	9.51e-05	CcSEcCtD
Tretinoin—Tachycardia—Dexamethasone—psoriasis	4.58e-06	9.51e-05	CcSEcCtD
Tretinoin—RARG—Gene Expression—PPARG—psoriasis	4.55e-06	0.000263	CbGpPWpGaD
Tretinoin—Hypersensitivity—Cyclosporine—psoriasis	4.55e-06	9.45e-05	CcSEcCtD
Tretinoin—Dyspepsia—Triamcinolone—psoriasis	4.55e-06	9.45e-05	CcSEcCtD
Tretinoin—Erythema multiforme—Methotrexate—psoriasis	4.55e-06	9.43e-05	CcSEcCtD
Tretinoin—Nausea—Mycophenolic acid—psoriasis	4.54e-06	9.42e-05	CcSEcCtD
Tretinoin—Hyperhidrosis—Dexamethasone—psoriasis	4.54e-06	9.42e-05	CcSEcCtD
Tretinoin—Hyperhidrosis—Betamethasone—psoriasis	4.54e-06	9.42e-05	CcSEcCtD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	4.53e-06	0.000262	CbGpPWpGaD
Tretinoin—Feeling abnormal—Hydrocortisone—psoriasis	4.53e-06	9.39e-05	CcSEcCtD
Tretinoin—Malaise—Prednisone—psoriasis	4.52e-06	9.37e-05	CcSEcCtD
Tretinoin—Eye disorder—Methotrexate—psoriasis	4.49e-06	9.32e-05	CcSEcCtD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.49e-06	0.00026	CbGpPWpGaD
Tretinoin—Gastrointestinal pain—Hydrocortisone—psoriasis	4.49e-06	9.32e-05	CcSEcCtD
Tretinoin—Syncope—Prednisone—psoriasis	4.49e-06	9.32e-05	CcSEcCtD
Tretinoin—Tinnitus—Methotrexate—psoriasis	4.48e-06	9.3e-05	CcSEcCtD
Tretinoin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	4.48e-06	0.000259	CbGpPWpGaD
Tretinoin—Anorexia—Betamethasone—psoriasis	4.47e-06	9.28e-05	CcSEcCtD
Tretinoin—Anorexia—Dexamethasone—psoriasis	4.47e-06	9.28e-05	CcSEcCtD
Tretinoin—Urticaria—Prednisolone—psoriasis	4.47e-06	9.27e-05	CcSEcCtD
Tretinoin—Fatigue—Triamcinolone—psoriasis	4.46e-06	9.26e-05	CcSEcCtD
Tretinoin—Hypersensitivity—Mycophenolate mofetil—psoriasis	4.44e-06	9.22e-05	CcSEcCtD
Tretinoin—Asthenia—Cyclosporine—psoriasis	4.43e-06	9.2e-05	CcSEcCtD
Tretinoin—Pain—Triamcinolone—psoriasis	4.42e-06	9.18e-05	CcSEcCtD
Tretinoin—Loss of consciousness—Prednisone—psoriasis	4.4e-06	9.14e-05	CcSEcCtD
Tretinoin—Hypotension—Betamethasone—psoriasis	4.38e-06	9.1e-05	CcSEcCtD
Tretinoin—Hypotension—Dexamethasone—psoriasis	4.38e-06	9.1e-05	CcSEcCtD
Tretinoin—Pruritus—Cyclosporine—psoriasis	4.37e-06	9.08e-05	CcSEcCtD
Tretinoin—Urticaria—Hydrocortisone—psoriasis	4.36e-06	9.06e-05	CcSEcCtD
Tretinoin—Angiopathy—Methotrexate—psoriasis	4.36e-06	9.05e-05	CcSEcCtD
Tretinoin—Body temperature increased—Hydrocortisone—psoriasis	4.34e-06	9.01e-05	CcSEcCtD
Tretinoin—Abdominal pain—Hydrocortisone—psoriasis	4.34e-06	9.01e-05	CcSEcCtD
Tretinoin—Convulsion—Prednisone—psoriasis	4.34e-06	9.01e-05	CcSEcCtD
Tretinoin—Asthenia—Mycophenolate mofetil—psoriasis	4.33e-06	8.98e-05	CcSEcCtD
Tretinoin—Hypertension—Prednisone—psoriasis	4.32e-06	8.97e-05	CcSEcCtD
Tretinoin—Chills—Methotrexate—psoriasis	4.31e-06	8.95e-05	CcSEcCtD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.28e-06	0.000247	CbGpPWpGaD
Tretinoin—Musculoskeletal discomfort—Dexamethasone—psoriasis	4.28e-06	8.87e-05	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Betamethasone—psoriasis	4.28e-06	8.87e-05	CcSEcCtD
Tretinoin—Pruritus—Mycophenolate mofetil—psoriasis	4.27e-06	8.85e-05	CcSEcCtD
Tretinoin—Myalgia—Prednisone—psoriasis	4.26e-06	8.85e-05	CcSEcCtD
Tretinoin—Arthralgia—Prednisone—psoriasis	4.26e-06	8.85e-05	CcSEcCtD
Tretinoin—Feeling abnormal—Triamcinolone—psoriasis	4.26e-06	8.85e-05	CcSEcCtD
Tretinoin—Anxiety—Prednisone—psoriasis	4.25e-06	8.82e-05	CcSEcCtD
Tretinoin—Alopecia—Methotrexate—psoriasis	4.25e-06	8.82e-05	CcSEcCtD
Tretinoin—Insomnia—Dexamethasone—psoriasis	4.24e-06	8.81e-05	CcSEcCtD
Tretinoin—Insomnia—Betamethasone—psoriasis	4.24e-06	8.81e-05	CcSEcCtD
Tretinoin—RXRA—Generic Transcription Pathway—PPARG—psoriasis	4.24e-06	0.000245	CbGpPWpGaD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	4.23e-06	8.79e-05	CcSEcCtD
Tretinoin—CYP2B6—Metabolism—CYP2S1—psoriasis	4.23e-06	0.000244	CbGpPWpGaD
Tretinoin—Diarrhoea—Cyclosporine—psoriasis	4.23e-06	8.78e-05	CcSEcCtD
Tretinoin—Paraesthesia—Betamethasone—psoriasis	4.21e-06	8.75e-05	CcSEcCtD
Tretinoin—Paraesthesia—Dexamethasone—psoriasis	4.21e-06	8.75e-05	CcSEcCtD
Tretinoin—Discomfort—Prednisone—psoriasis	4.21e-06	8.74e-05	CcSEcCtD
Tretinoin—Mental disorder—Methotrexate—psoriasis	4.21e-06	8.74e-05	CcSEcCtD
Tretinoin—CYP2C8—Metabolism—NDUFA5—psoriasis	4.21e-06	0.000243	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—CARM1—psoriasis	4.2e-06	0.000243	CbGpPWpGaD
Tretinoin—Malnutrition—Methotrexate—psoriasis	4.18e-06	8.69e-05	CcSEcCtD
Tretinoin—Erythema—Methotrexate—psoriasis	4.18e-06	8.69e-05	CcSEcCtD
Tretinoin—RXRG—Gene Expression—PPARG—psoriasis	4.16e-06	0.000241	CbGpPWpGaD
Tretinoin—Hypersensitivity—Prednisolone—psoriasis	4.14e-06	8.6e-05	CcSEcCtD
Tretinoin—CYP3A5—Metabolism—CYP2S1—psoriasis	4.13e-06	0.000239	CbGpPWpGaD
Tretinoin—Dyspepsia—Betamethasone—psoriasis	4.13e-06	8.57e-05	CcSEcCtD
Tretinoin—Dyspepsia—Dexamethasone—psoriasis	4.13e-06	8.57e-05	CcSEcCtD
Tretinoin—Diarrhoea—Mycophenolate mofetil—psoriasis	4.12e-06	8.56e-05	CcSEcCtD
Tretinoin—Urticaria—Triamcinolone—psoriasis	4.11e-06	8.53e-05	CcSEcCtD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.09e-06	0.000236	CbGpPWpGaD
Tretinoin—Body temperature increased—Triamcinolone—psoriasis	4.09e-06	8.49e-05	CcSEcCtD
Tretinoin—Dizziness—Cyclosporine—psoriasis	4.09e-06	8.48e-05	CcSEcCtD
Tretinoin—Anaphylactic shock—Prednisone—psoriasis	4.09e-06	8.48e-05	CcSEcCtD
Tretinoin—Oedema—Prednisone—psoriasis	4.09e-06	8.48e-05	CcSEcCtD
Tretinoin—RARB—Gene Expression—PPARG—psoriasis	4.08e-06	0.000236	CbGpPWpGaD
Tretinoin—Decreased appetite—Betamethasone—psoriasis	4.08e-06	8.47e-05	CcSEcCtD
Tretinoin—Decreased appetite—Dexamethasone—psoriasis	4.08e-06	8.47e-05	CcSEcCtD
Tretinoin—Infection—Prednisone—psoriasis	4.06e-06	8.43e-05	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Dexamethasone—psoriasis	4.05e-06	8.41e-05	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Betamethasone—psoriasis	4.05e-06	8.41e-05	CcSEcCtD
Tretinoin—Back pain—Methotrexate—psoriasis	4.05e-06	8.4e-05	CcSEcCtD
Tretinoin—Hypersensitivity—Hydrocortisone—psoriasis	4.05e-06	8.4e-05	CcSEcCtD
Tretinoin—Fatigue—Dexamethasone—psoriasis	4.05e-06	8.4e-05	CcSEcCtD
Tretinoin—Fatigue—Betamethasone—psoriasis	4.05e-06	8.4e-05	CcSEcCtD
Tretinoin—Shock—Prednisone—psoriasis	4.02e-06	8.35e-05	CcSEcCtD
Tretinoin—Pain—Betamethasone—psoriasis	4.01e-06	8.33e-05	CcSEcCtD
Tretinoin—Pain—Dexamethasone—psoriasis	4.01e-06	8.33e-05	CcSEcCtD
Tretinoin—Nervous system disorder—Prednisone—psoriasis	4.01e-06	8.32e-05	CcSEcCtD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	3.99e-06	0.000231	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—PPARG—psoriasis	3.99e-06	0.000231	CbGpPWpGaD
Tretinoin—Tachycardia—Prednisone—psoriasis	3.99e-06	8.28e-05	CcSEcCtD
Tretinoin—Dizziness—Mycophenolate mofetil—psoriasis	3.99e-06	8.28e-05	CcSEcCtD
Tretinoin—Skin disorder—Prednisone—psoriasis	3.97e-06	8.24e-05	CcSEcCtD
Tretinoin—Hyperhidrosis—Prednisone—psoriasis	3.95e-06	8.2e-05	CcSEcCtD
Tretinoin—Vision blurred—Methotrexate—psoriasis	3.94e-06	8.19e-05	CcSEcCtD
Tretinoin—Asthenia—Hydrocortisone—psoriasis	3.94e-06	8.18e-05	CcSEcCtD
Tretinoin—Vomiting—Cyclosporine—psoriasis	3.93e-06	8.16e-05	CcSEcCtD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.93e-06	0.000227	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—PPARG—psoriasis	3.92e-06	0.000226	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—PPARG—psoriasis	3.92e-06	0.000226	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYP2S1—psoriasis	3.91e-06	0.000226	CbGpPWpGaD
Tretinoin—Rash—Cyclosporine—psoriasis	3.9e-06	8.09e-05	CcSEcCtD
Tretinoin—Anorexia—Prednisone—psoriasis	3.9e-06	8.09e-05	CcSEcCtD
Tretinoin—Dermatitis—Cyclosporine—psoriasis	3.89e-06	8.08e-05	CcSEcCtD
Tretinoin—Pruritus—Hydrocortisone—psoriasis	3.89e-06	8.07e-05	CcSEcCtD
Tretinoin—Ill-defined disorder—Methotrexate—psoriasis	3.88e-06	8.06e-05	CcSEcCtD
Tretinoin—Headache—Cyclosporine—psoriasis	3.87e-06	8.04e-05	CcSEcCtD
Tretinoin—Anaemia—Methotrexate—psoriasis	3.87e-06	8.03e-05	CcSEcCtD
Tretinoin—Feeling abnormal—Dexamethasone—psoriasis	3.87e-06	8.03e-05	CcSEcCtD
Tretinoin—Feeling abnormal—Betamethasone—psoriasis	3.87e-06	8.03e-05	CcSEcCtD
Tretinoin—Gastrointestinal pain—Dexamethasone—psoriasis	3.84e-06	7.96e-05	CcSEcCtD
Tretinoin—Gastrointestinal pain—Betamethasone—psoriasis	3.84e-06	7.96e-05	CcSEcCtD
Tretinoin—Vomiting—Mycophenolate mofetil—psoriasis	3.83e-06	7.96e-05	CcSEcCtD
Tretinoin—RXRA—Metabolism—CARM1—psoriasis	3.81e-06	0.00022	CbGpPWpGaD
Tretinoin—Hypersensitivity—Triamcinolone—psoriasis	3.81e-06	7.91e-05	CcSEcCtD
Tretinoin—Rash—Mycophenolate mofetil—psoriasis	3.8e-06	7.89e-05	CcSEcCtD
Tretinoin—Dermatitis—Mycophenolate mofetil—psoriasis	3.8e-06	7.88e-05	CcSEcCtD
Tretinoin—Headache—Mycophenolate mofetil—psoriasis	3.78e-06	7.84e-05	CcSEcCtD
Tretinoin—Malaise—Methotrexate—psoriasis	3.77e-06	7.83e-05	CcSEcCtD
Tretinoin—Diarrhoea—Hydrocortisone—psoriasis	3.76e-06	7.8e-05	CcSEcCtD
Tretinoin—Urticaria—Dexamethasone—psoriasis	3.73e-06	7.74e-05	CcSEcCtD
Tretinoin—Urticaria—Betamethasone—psoriasis	3.73e-06	7.74e-05	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Prednisone—psoriasis	3.72e-06	7.73e-05	CcSEcCtD
Tretinoin—Dizziness—Prednisolone—psoriasis	3.72e-06	7.72e-05	CcSEcCtD
Tretinoin—Asthenia—Triamcinolone—psoriasis	3.71e-06	7.7e-05	CcSEcCtD
Tretinoin—Body temperature increased—Betamethasone—psoriasis	3.71e-06	7.7e-05	CcSEcCtD
Tretinoin—Abdominal pain—Betamethasone—psoriasis	3.71e-06	7.7e-05	CcSEcCtD
Tretinoin—Abdominal pain—Dexamethasone—psoriasis	3.71e-06	7.7e-05	CcSEcCtD
Tretinoin—Body temperature increased—Dexamethasone—psoriasis	3.71e-06	7.7e-05	CcSEcCtD
Tretinoin—Insomnia—Prednisone—psoriasis	3.7e-06	7.67e-05	CcSEcCtD
Tretinoin—Nausea—Cyclosporine—psoriasis	3.67e-06	7.62e-05	CcSEcCtD
Tretinoin—Paraesthesia—Prednisone—psoriasis	3.67e-06	7.62e-05	CcSEcCtD
Tretinoin—Pruritus—Triamcinolone—psoriasis	3.66e-06	7.59e-05	CcSEcCtD
Tretinoin—Cough—Methotrexate—psoriasis	3.65e-06	7.58e-05	CcSEcCtD
Tretinoin—Dizziness—Hydrocortisone—psoriasis	3.63e-06	7.54e-05	CcSEcCtD
Tretinoin—Convulsion—Methotrexate—psoriasis	3.63e-06	7.53e-05	CcSEcCtD
Tretinoin—Dyspepsia—Prednisone—psoriasis	3.6e-06	7.47e-05	CcSEcCtD
Tretinoin—Nausea—Mycophenolate mofetil—psoriasis	3.58e-06	7.43e-05	CcSEcCtD
Tretinoin—CYP2C8—Metabolism—CYP2S1—psoriasis	3.58e-06	0.000207	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.56e-06	0.000206	CbGpPWpGaD
Tretinoin—Myalgia—Methotrexate—psoriasis	3.56e-06	7.4e-05	CcSEcCtD
Tretinoin—Chest pain—Methotrexate—psoriasis	3.56e-06	7.4e-05	CcSEcCtD
Tretinoin—Arthralgia—Methotrexate—psoriasis	3.56e-06	7.4e-05	CcSEcCtD
Tretinoin—Decreased appetite—Prednisone—psoriasis	3.55e-06	7.37e-05	CcSEcCtD
Tretinoin—Rash—Prednisolone—psoriasis	3.55e-06	7.36e-05	CcSEcCtD
Tretinoin—Dermatitis—Prednisolone—psoriasis	3.54e-06	7.35e-05	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	3.54e-06	7.34e-05	CcSEcCtD
Tretinoin—Fatigue—Prednisone—psoriasis	3.52e-06	7.31e-05	CcSEcCtD
Tretinoin—Headache—Prednisolone—psoriasis	3.52e-06	7.31e-05	CcSEcCtD
Tretinoin—Discomfort—Methotrexate—psoriasis	3.52e-06	7.31e-05	CcSEcCtD
Tretinoin—RXRA—Developmental Biology—TYK2—psoriasis	3.5e-06	0.000202	CbGpPWpGaD
Tretinoin—Constipation—Prednisone—psoriasis	3.49e-06	7.25e-05	CcSEcCtD
Tretinoin—Vomiting—Hydrocortisone—psoriasis	3.49e-06	7.25e-05	CcSEcCtD
Tretinoin—Rash—Hydrocortisone—psoriasis	3.46e-06	7.19e-05	CcSEcCtD
Tretinoin—Dermatitis—Hydrocortisone—psoriasis	3.46e-06	7.18e-05	CcSEcCtD
Tretinoin—Confusional state—Methotrexate—psoriasis	3.44e-06	7.15e-05	CcSEcCtD
Tretinoin—Headache—Hydrocortisone—psoriasis	3.44e-06	7.14e-05	CcSEcCtD
Tretinoin—CYP2C9—Metabolism—NDUFA5—psoriasis	3.43e-06	0.000198	CbGpPWpGaD
Tretinoin—Dizziness—Triamcinolone—psoriasis	3.42e-06	7.1e-05	CcSEcCtD
Tretinoin—Anaphylactic shock—Methotrexate—psoriasis	3.42e-06	7.09e-05	CcSEcCtD
Tretinoin—Infection—Methotrexate—psoriasis	3.39e-06	7.04e-05	CcSEcCtD
Tretinoin—Feeling abnormal—Prednisone—psoriasis	3.37e-06	6.99e-05	CcSEcCtD
Tretinoin—Asthenia—Dexamethasone—psoriasis	3.37e-06	6.99e-05	CcSEcCtD
Tretinoin—Asthenia—Betamethasone—psoriasis	3.37e-06	6.99e-05	CcSEcCtD
Tretinoin—Nervous system disorder—Methotrexate—psoriasis	3.35e-06	6.95e-05	CcSEcCtD
Tretinoin—Thrombocytopenia—Methotrexate—psoriasis	3.34e-06	6.94e-05	CcSEcCtD
Tretinoin—Gastrointestinal pain—Prednisone—psoriasis	3.34e-06	6.94e-05	CcSEcCtD
Tretinoin—Nausea—Prednisolone—psoriasis	3.34e-06	6.93e-05	CcSEcCtD
Tretinoin—Pruritus—Dexamethasone—psoriasis	3.32e-06	6.89e-05	CcSEcCtD
Tretinoin—Pruritus—Betamethasone—psoriasis	3.32e-06	6.89e-05	CcSEcCtD
Tretinoin—Skin disorder—Methotrexate—psoriasis	3.32e-06	6.89e-05	CcSEcCtD
Tretinoin—Hyperhidrosis—Methotrexate—psoriasis	3.3e-06	6.85e-05	CcSEcCtD
Tretinoin—Vomiting—Triamcinolone—psoriasis	3.29e-06	6.83e-05	CcSEcCtD
Tretinoin—Nausea—Hydrocortisone—psoriasis	3.26e-06	6.77e-05	CcSEcCtD
Tretinoin—Rash—Triamcinolone—psoriasis	3.26e-06	6.77e-05	CcSEcCtD
Tretinoin—Dermatitis—Triamcinolone—psoriasis	3.26e-06	6.76e-05	CcSEcCtD
Tretinoin—Anorexia—Methotrexate—psoriasis	3.26e-06	6.76e-05	CcSEcCtD
Tretinoin—Urticaria—Prednisone—psoriasis	3.25e-06	6.74e-05	CcSEcCtD
Tretinoin—Headache—Triamcinolone—psoriasis	3.24e-06	6.72e-05	CcSEcCtD
Tretinoin—Abdominal pain—Prednisone—psoriasis	3.23e-06	6.71e-05	CcSEcCtD
Tretinoin—Body temperature increased—Prednisone—psoriasis	3.23e-06	6.71e-05	CcSEcCtD
Tretinoin—Diarrhoea—Dexamethasone—psoriasis	3.21e-06	6.66e-05	CcSEcCtD
Tretinoin—Diarrhoea—Betamethasone—psoriasis	3.21e-06	6.66e-05	CcSEcCtD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.2e-06	0.000185	CbGpPWpGaD
Tretinoin—Hypotension—Methotrexate—psoriasis	3.19e-06	6.62e-05	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Methotrexate—psoriasis	3.11e-06	6.46e-05	CcSEcCtD
Tretinoin—Dizziness—Dexamethasone—psoriasis	3.1e-06	6.44e-05	CcSEcCtD
Tretinoin—Dizziness—Betamethasone—psoriasis	3.1e-06	6.44e-05	CcSEcCtD
Tretinoin—Insomnia—Methotrexate—psoriasis	3.09e-06	6.41e-05	CcSEcCtD
Tretinoin—Nausea—Triamcinolone—psoriasis	3.07e-06	6.38e-05	CcSEcCtD
Tretinoin—Paraesthesia—Methotrexate—psoriasis	3.07e-06	6.37e-05	CcSEcCtD
Tretinoin—Dyspnoea—Methotrexate—psoriasis	3.04e-06	6.32e-05	CcSEcCtD
Tretinoin—Somnolence—Methotrexate—psoriasis	3.04e-06	6.3e-05	CcSEcCtD
Tretinoin—Hypersensitivity—Prednisone—psoriasis	3.01e-06	6.25e-05	CcSEcCtD
Tretinoin—Dyspepsia—Methotrexate—psoriasis	3.01e-06	6.24e-05	CcSEcCtD
Tretinoin—Vomiting—Dexamethasone—psoriasis	2.98e-06	6.19e-05	CcSEcCtD
Tretinoin—Vomiting—Betamethasone—psoriasis	2.98e-06	6.19e-05	CcSEcCtD
Tretinoin—Decreased appetite—Methotrexate—psoriasis	2.97e-06	6.16e-05	CcSEcCtD
Tretinoin—Rash—Dexamethasone—psoriasis	2.96e-06	6.14e-05	CcSEcCtD
Tretinoin—Rash—Betamethasone—psoriasis	2.96e-06	6.14e-05	CcSEcCtD
Tretinoin—CYP4A11—Metabolism—CAT—psoriasis	2.96e-06	0.000171	CbGpPWpGaD
Tretinoin—Dermatitis—Dexamethasone—psoriasis	2.96e-06	6.14e-05	CcSEcCtD
Tretinoin—Dermatitis—Betamethasone—psoriasis	2.96e-06	6.14e-05	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Methotrexate—psoriasis	2.95e-06	6.12e-05	CcSEcCtD
Tretinoin—Fatigue—Methotrexate—psoriasis	2.94e-06	6.11e-05	CcSEcCtD
Tretinoin—Headache—Dexamethasone—psoriasis	2.94e-06	6.1e-05	CcSEcCtD
Tretinoin—Headache—Betamethasone—psoriasis	2.94e-06	6.1e-05	CcSEcCtD
Tretinoin—Asthenia—Prednisone—psoriasis	2.93e-06	6.09e-05	CcSEcCtD
Tretinoin—RXRA—Gene Expression—VDR—psoriasis	2.93e-06	0.000169	CbGpPWpGaD
Tretinoin—Pain—Methotrexate—psoriasis	2.92e-06	6.06e-05	CcSEcCtD
Tretinoin—CYP2C9—Metabolism—CYP2S1—psoriasis	2.91e-06	0.000168	CbGpPWpGaD
Tretinoin—Pruritus—Prednisone—psoriasis	2.89e-06	6e-05	CcSEcCtD
Tretinoin—Feeling abnormal—Methotrexate—psoriasis	2.81e-06	5.84e-05	CcSEcCtD
Tretinoin—Diarrhoea—Prednisone—psoriasis	2.8e-06	5.8e-05	CcSEcCtD
Tretinoin—Gastrointestinal pain—Methotrexate—psoriasis	2.79e-06	5.8e-05	CcSEcCtD
Tretinoin—CYP3A7—Metabolism—CARM1—psoriasis	2.79e-06	0.000161	CbGpPWpGaD
Tretinoin—Nausea—Betamethasone—psoriasis	2.79e-06	5.79e-05	CcSEcCtD
Tretinoin—Nausea—Dexamethasone—psoriasis	2.79e-06	5.79e-05	CcSEcCtD
Tretinoin—RXRA—Developmental Biology—NFKB1—psoriasis	2.72e-06	0.000157	CbGpPWpGaD
Tretinoin—Urticaria—Methotrexate—psoriasis	2.71e-06	5.63e-05	CcSEcCtD
Tretinoin—Dizziness—Prednisone—psoriasis	2.7e-06	5.61e-05	CcSEcCtD
Tretinoin—Abdominal pain—Methotrexate—psoriasis	2.7e-06	5.6e-05	CcSEcCtD
Tretinoin—Body temperature increased—Methotrexate—psoriasis	2.7e-06	5.6e-05	CcSEcCtD
Tretinoin—Vomiting—Prednisone—psoriasis	2.6e-06	5.39e-05	CcSEcCtD
Tretinoin—CYP2C18—Metabolism—CAT—psoriasis	2.58e-06	0.000149	CbGpPWpGaD
Tretinoin—Rash—Prednisone—psoriasis	2.58e-06	5.35e-05	CcSEcCtD
Tretinoin—Dermatitis—Prednisone—psoriasis	2.57e-06	5.34e-05	CcSEcCtD
Tretinoin—Headache—Prednisone—psoriasis	2.56e-06	5.31e-05	CcSEcCtD
Tretinoin—CYP2A6—Metabolism—CARM1—psoriasis	2.56e-06	0.000148	CbGpPWpGaD
Tretinoin—Hypersensitivity—Methotrexate—psoriasis	2.52e-06	5.22e-05	CcSEcCtD
Tretinoin—RXRA—Developmental Biology—VEGFA—psoriasis	2.47e-06	0.000143	CbGpPWpGaD
Tretinoin—Asthenia—Methotrexate—psoriasis	2.45e-06	5.09e-05	CcSEcCtD
Tretinoin—RXRA—Developmental Biology—STAT3—psoriasis	2.45e-06	0.000141	CbGpPWpGaD
Tretinoin—Nausea—Prednisone—psoriasis	2.43e-06	5.04e-05	CcSEcCtD
Tretinoin—Pruritus—Methotrexate—psoriasis	2.42e-06	5.02e-05	CcSEcCtD
Tretinoin—RXRA—Metabolism—CAT—psoriasis	2.34e-06	0.000135	CbGpPWpGaD
Tretinoin—Diarrhoea—Methotrexate—psoriasis	2.34e-06	4.85e-05	CcSEcCtD
Tretinoin—CYP4A11—Metabolism—APOE—psoriasis	2.3e-06	0.000133	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NDUFA5—psoriasis	2.26e-06	0.000131	CbGpPWpGaD
Tretinoin—Dizziness—Methotrexate—psoriasis	2.26e-06	4.69e-05	CcSEcCtD
Tretinoin—Vomiting—Methotrexate—psoriasis	2.17e-06	4.51e-05	CcSEcCtD
Tretinoin—Rash—Methotrexate—psoriasis	2.15e-06	4.47e-05	CcSEcCtD
Tretinoin—Dermatitis—Methotrexate—psoriasis	2.15e-06	4.47e-05	CcSEcCtD
Tretinoin—Headache—Methotrexate—psoriasis	2.14e-06	4.44e-05	CcSEcCtD
Tretinoin—RXRA—Developmental Biology—TNF—psoriasis	2.12e-06	0.000122	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CARM1—psoriasis	2.07e-06	0.000119	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.05e-06	0.000118	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—PPARG—psoriasis	2.04e-06	0.000118	CbGpPWpGaD
Tretinoin—Nausea—Methotrexate—psoriasis	2.03e-06	4.21e-05	CcSEcCtD
Tretinoin—CYP3A5—Metabolism—CARM1—psoriasis	2.02e-06	0.000117	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—APOE—psoriasis	2.01e-06	0.000116	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PPARG—psoriasis	2e-06	0.000116	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP2S1—psoriasis	1.92e-06	0.000111	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CARM1—psoriasis	1.91e-06	0.00011	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.88e-06	0.000108	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—APOE—psoriasis	1.82e-06	0.000105	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.78e-06	0.000103	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PPARG—psoriasis	1.75e-06	0.000101	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CARM1—psoriasis	1.75e-06	0.000101	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CAT—psoriasis	1.72e-06	9.93e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—IL6—psoriasis	1.71e-06	9.88e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.63e-06	9.45e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PPARG—psoriasis	1.59e-06	9.17e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CAT—psoriasis	1.57e-06	9.1e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.53e-06	8.83e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CARM1—psoriasis	1.42e-06	8.22e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—APOE—psoriasis	1.33e-06	7.71e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.33e-06	7.69e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CAT—psoriasis	1.27e-06	7.34e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CAT—psoriasis	1.24e-06	7.18e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—APOE—psoriasis	1.22e-06	7.07e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CAT—psoriasis	1.17e-06	6.78e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PPARG—psoriasis	1.16e-06	6.72e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CAT—psoriasis	1.08e-06	6.22e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PPARG—psoriasis	1.07e-06	6.16e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—APOE—psoriasis	9.87e-07	5.7e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—APOE—psoriasis	9.65e-07	5.58e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CARM1—psoriasis	9.39e-07	5.42e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—APOE—psoriasis	9.11e-07	5.27e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CAT—psoriasis	8.75e-07	5.06e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PPARG—psoriasis	8.6e-07	4.97e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PPARG—psoriasis	8.4e-07	4.86e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—APOE—psoriasis	8.36e-07	4.83e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PPARG—psoriasis	7.94e-07	4.59e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PPARG—psoriasis	7.28e-07	4.21e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—APOE—psoriasis	6.8e-07	3.93e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PPARG—psoriasis	5.92e-07	3.42e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CAT—psoriasis	5.77e-07	3.34e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—APOE—psoriasis	4.49e-07	2.59e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PPARG—psoriasis	3.91e-07	2.26e-05	CbGpPWpGaD
